###begin article-title 0
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Sequence variations of GRM6 in patients with high myopia
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 191 199 <span type="species:ncbi:9606">patients</span>
Mutations in the glutamate receptor metabotropic 6 gene (GRM6) have been identified in patients with congenital stationary night blindness (CSNB1B). High myopia is usually observed in CSNB1B patients. This study tested if any mutations in GRM6 were solely responsible for high myopia.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
DNA was prepared from the venous leukocytes of 96 Chinese patients with high myopia (refraction of spherical equivalent of at least -6.00 diopters [D]) and 96 controls (refraction of spherical equivalent between -0.50 D and +2.00 D with normal visual acuity). The coding regions and adjacent intronic sequence of GRM6 were amplified by a polymerase chain reaction (PCR) and then analyzed by cycle sequencing. Detected variations were evaluated in normal controls by heteroduplex-single-strand-conformation (SSCP) polymorphism analysis or restriction fragment polymorphism (RFLP).
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
Four novel variations predicted to have potential functional changes were identified: c.67-82delCAGGCGGGCCTGGCGCinsT (p.Gln23_Arg28delinsCys), c.858-5a>g (r.spl?), c.1172G>A (p.Arg391Gln), and c.1537G>A (p.Val513Met). Except for c.1172G>A, the other three were not detected in the 96 controls. In addition, five rare variations-(c.72G>A, c.504+10g>t, c.726-50g>c, c.1359C>T, and c.1383C>T)-and one common variation (c.2437-6g>a) without predicted functional consequences and nine known single nucleotide polymorphisms (SNPs) were also detected.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
Three novel variations with potential functional consequences were identified in the GRM6 of patients with high myopia, suggesting a potential role in the development of myopia in rare cases.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 258 259 258 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 1218 1219 1218 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 1220 1221 1220 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 433 436 <span type="species:ncbi:10116">rat</span>
The glutamate receptor metabotropic 6 gene (GRM6; OMIM ), mapped to 5q35, contained 10 exons and encoded an 877 amino acid protein, mGluR6. As a member of Group III mGluRs (mGluR4, 6, 7, and 8), it contains a signal peptide, a large bi-lobed extracellular NH2-terminal domain containing the glutamate binding site, seven G protein-coupled receptor (GPCR) transmembrane domains and an intracellular COOH-terminal domain [1-3]. In the rat retina, mGluR6 is specifically expressed in ON bipolar cells at the postsynaptic site [4]. In the retinal neural network, an increase in light reduced the release of glutamate from cones and rods, while a decrease in light increases its release, which acted as inputs from photoreceptors to bipolar cells. The visual signals of light and dark were segregated into parallel ON and OFF pathways through ON and OFF bipolar cells. The ON bipolar cells utilize a metabotropic glutamate receptor (mGluR6) for a light-activated depolarization, whereas the OFF bipolar cells utilized ionotropic glutamate receptors (iGluRs) for a light-activated hyperpolarization. ON and OFF bipolar cells made synaptic contacts with ON and OFF ganglion cells and transmitted visual signals to the brain [5-8].
###end p 10
###begin p 11
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 239 242 239 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NYX</italic>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 426 429 426 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NYX</italic>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 474 477 474 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nyx</italic>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 593 596 593 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NYX</italic>
###xml 677 679 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 763 767 763 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 813 817 813 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 955 956 955 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 412 420 <span type="species:ncbi:9606">patients</span>
###xml 457 462 <span type="species:ncbi:10090">mouse</span>
###xml 749 757 <span type="species:ncbi:9606">patients</span>
###xml 789 794 <span type="species:ncbi:10090">mouse</span>
Functional defects involving retinal ON-pathways have been demonstrated by retinal electrophysiology studies in the complete form of congenital stationary night blindness, including CSNB1A (OMIM ) and CSNB1B (OMIM ) [7,9-12]. Mutations in NYX or GRM6 are responsible for CSNB1A or CSNB1B, respectively [10,11,13-15]. Besides night blindness, high myopia is also frequently documented as a typical sign in CSNB1A patients with NYX mutations [13,14,16-18]. A mouse model with Nyx mutation and retinal ON-pathway defect has high susceptibility to experimental myopia [19]. Recently, mutations in NYX have been reported to associate with high myopia alone without night blindness [20]. Similarly, moderate to high myopia is also a common sign in CSNB1B patients with GRM6 mutations [10,21]. A mouse model lacking the GRM6 gene showed a loss of ON response, but an unchanged OFF response to light, demonstrating its essential role in ON synaptic transmission [4].
###end p 11
###begin p 12
###xml 81 138 81 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAT1, PDE6B, RHO, CABP4, GRK1, GRM6, RDH5, SAG, CACNA1F,</italic>
###xml 143 146 143 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NYX</italic>
###xml 238 241 238 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NYX</italic>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 359 363 359 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 417 420 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NYX</italic>
###xml 442 446 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 565 569 565 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 584 592 <span type="species:ncbi:9606">patients</span>
Congenital stationary night blindness (CSNB) can be caused by mutations in genes GNAT1, PDE6B, RHO, CABP4, GRK1, GRM6, RDH5, SAG, CACNA1F, and NYX (). Myopia is not always associated with CSNB, except in cases resulting from mutations in NYX and GRM6 [10,16], suggesting a gene-specific phenotype rather than association with night blindness. As mutations in GRM6 resulted in phenotypes extremely similar to those in NYX, this suggested that GRM6 might be a candidate susceptibility gene for isolated high myopia. In this study, we analyzed the genomic sequence of GRM6 in 96 Chinese patients with high myopia.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Subjects
###end title 14
###begin p 15
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 974 977 974 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 224 236 <span type="species:ncbi:9606">participants</span>
Ninety-six unrelated probands with high myopia and 96 unrelated normal controls were collected from Zhongshan Ophthalmic Center. Informed consent conforming to the tenets of the Declaration of Helsinki was obtained from the participants prior to the study. This study was approved by the Institutional Review Boards of Zhongshan Ophthalmic Center. Ophthalmological examinations were performed by ophthalmologists (Drs. Q.Z. and X.G.). The diagnostic criteria for high myopia were as we previously described [22]: 1) bilateral refraction of -6.00D or lower (spherical equivalent) and 2) no other known ocular or systemic diseases associated with high myopia. Normal controls met the following criteria: 1) bilateral refraction between -0.50 D and +2.00 D with normal visual acuity, 2) no family history of high myopia, and 3) exclusion of known ocular or systemic diseases. The refractive error of all eyes was measured with cycloplegic autorefraction after mydriasis (Mydrin(R)-P, a compound tropicamide; Santen Pharmaceutical Co. Ltd., Osaka, Japan). Genomic DNA was prepared from venous blood.
###end p 15
###begin title 16
Variation analysis
###end title 16
###begin p 17
###xml 24 31 24 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 449 456 449 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 626 630 626 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 952 959 952 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 634 642 <span type="species:ncbi:9606">patients</span>
Seven pairs of primers (Table 1) were used to amplify the 10 coding exons and the adjacent intronic sequence of GRM6 (human genome build 36.2  for gDNA,  for mRNA, and  for protein). DNA fragments from individual exons were amplified by touchdown PCR where higher annealing temperatures were set for the first five cycles, followed by moderate annealing temperature for the next five cycles and finally by a lower annealing temperature as listed in Table 1 for the remaining 23 cycles. The procedures for sequencing and variation detection were basically the same as previously described [22]. Potential mutations detected in GRM6 of patients were further evaluated in the 96 controls by using either heteroduplex-single-strand-conformational polymorphism (HA-SSCP) [23] or polymerase chain reaction combined with restriction fragment length polymorphism (PCR-RFLP) analysis [24]. Extra pairs of primers were designed for HA-SSCP or PCR-RFLP analysis (Table 2). The 102 bp amplicons with the c.1172G>A variation were cut into 26 bp and 76 bp as the variation created a new BstNI site, while the wild amplicons remained unchanged. The 136 bp amplicons with the c.1537G>A variation could not be digested by Bsp1286I since the variation erased the Bsp1286I site that presented in wild type amplicons. The variation of c.1172G>A was genotyped and statistically analyzed using continuity correction of Pearson's Chi-Square test with a significance level of 0.05.
###end p 17
###begin title 18
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
Primers used for polymerase chain reaction amplification and direct sequencing of GRM6.
###end title 18
###begin p 19
In the "Primer sequence" column, "F" indicates the forward primer and "R" indicates the reverse primer. GC1 buffer (Takara Biotechnology Dalian CO. Ltd, Liaoning, China) is designed for amplification of templates having complex secondary structure or high GC content. LA Taq DNA Polymerase (Takara Biotechnology Dalian CO. Ltd, Liaoning, China) was designed for amplification of long targets. The amplicon from exon 4 to 7 was sequenced with the additional primers listed as F1, F2, R1 and R2.
###end p 19
###begin title 20
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
Primers used for evaluating the variations by HA-SSCP or PCR-RFLP analysis of GRM6.
###end title 20
###begin title 21
Database and online tools
###end title 21
###begin p 22
###xml 30 32 30 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 33 35 33 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 230 240 <span type="species:ncbi:7227">Drosophila</span>
 Polymorphism Phenotyping () [25-27] and Sorting Intolerant From Tolerant () [28] were used to evaluate the potential pathogenicity of sequence alterations at the protein level. Automated Splice Site Analysis () [29] and Berkeley Drosophila Genome Project () [30] were used for predicting the alterations of splicing sites. National Center for Biotechnology Information (), Conserved Domain Database (), ,  [31,32], Simple Modular Architecture Research Tool () [33,34], and  [35,36] were used for analyzing structures and functions of protein domains and predicting protein topology and subcellular localization. Search Tool for the Retrieval of Interacting Genes/Proteins () was used for showing and predicting protein interactions [37].
###end p 22
###begin title 23
Results
###end title 23
###begin p 24
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 285 297 285 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figures 1A,B</xref>
###xml 299 306 299 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 425 434 425 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 994 1001 994 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 37 45 <span type="species:ncbi:9606">patients</span>
###xml 813 821 <span type="species:ncbi:9606">patients</span>
###xml 984 992 <span type="species:ncbi:9606">patients</span>
Upon complete analysis of GRM6 in 96 patients with high myopia, four novel variations predicted to have potential functional consequence were identified: c.67-82delCAGGCGGGCCTGGCGCinsT (p.Gln23_Arg28delinsCys), c.858-5a>g (r.spl?), c.1172G>A (p.Arg391Gln), and c.1537G>A (p.Val513Met; Figures 1A,B; Table 3). The c.67-82delCAGGCGGGCCTGGCGCinsT (p.Gln23_Arg28delinsCys) variation was further determined by cloning sequencing (Figure 1A). Of the four variations, three were not present in the 96 controls but the other one (c.1172G>A) was detected in four of the 96 controls. In addition, five rare variations (c.72G>A, c.504+10g>t, c.726-50g>c, c.1359C>T, and c.1383C>T) and a common variation (c.2437-6g>a) without predicted functional consequence by the abovementioned online tools [25-30] were also detected in patients with high myopia, but the presence of these variations in controls was not examined. Furthermore, nine reported SNPs (, , , , , , , , and ) were also detected in patients (Table 3).
###end p 24
###begin p 25
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 96 97 96 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 264 265 264 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 434 435 434 435 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 634 635 634 635 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 640 641 640 641 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 710 711 710 711 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 763 764 763 764 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
Four novel variations were detected in GRM6 of 96 unrelated subjects with isolated high myopia. A: Sequences with c.67-82delCAGGCGGGCCTGGCGCinsT p.Gln23_Arg28delinsCys variation, normal control, as well as cloning sequences of both forward and reverse directions. B: Sequences showing the rest three novel variations as well as normal controls. The substitute bases are highlighted by an arrow, with protein consequence marked below. C: Variations were not observed in normal controls (NC) by SSCP or RFLP, with the exception of c.1172G>A p.Arg391Gln. Plus signs indicate samples with variation; minus signs indicate normal controls. D and E: Conservation analysis of the variations between different species (D) or between different members of Group III mGluRs (E).
###end p 25
###begin title 26
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Sequence variations in GRM6 detected in 96 high myopia patients.
###end title 26
###begin p 27
###xml 116 124 <span type="species:ncbi:9606">patients</span>
The novel variations are highlighted in bold. An asterisk indicates that there is no statistical difference between patients and controls. ND: no detected.
###end p 27
###begin p 28
###xml 429 442 429 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figures 1D, E</xref>
###xml 700 701 700 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 90 97 <span type="species:ncbi:9606">patient</span>
The c.67-82delCAGGCGGGCCTGGCGCinsT (p.Gln23_Arg28delinsCys) variation was detected in one patient in a heterozygous status, but not in the 96 controls. It was a del_ins variation without frame shifting, resulting in the deletion of six residues and the addition of cysteine at protein. Conserved domain analysis showed the affected oligopeptide was not conserved among different species or different members of Group III mGluRs (Figures 1D, E). Functional domain prediction revealed that amino acid residues one to 24 of mGluR6 would act as the signal peptide, and the following 25 to 585 amino acid residues would form an extracellular N-terminal domain related to periplasmic ligand binding. The NH2-terminal domain is vital in glutamate binding and the activation/inactivation of mGluR6 [38,39].
###end p 28
###begin p 29
###xml 45 52 <span type="species:ncbi:9606">patient</span>
The c.858-5a>g variation was detected in one patient, but not in the 96 controls. Analysis of the corresponding splicing site by both the ASSA server and the BDGP server revealed a comparatively weak leaky effect (from 9.6 to 9.3), resulting in a -1.2 fold decrease on the natural splicing acceptor site.
###end p 29
###begin p 30
###xml 325 342 325 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rattus norvegicus</italic>
###xml 347 359 347 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 421 434 421 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figures 1D, E</xref>
###xml 476 477 476 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 852 853 850 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 860 867 858 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 325 342 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 347 359 <span type="species:ncbi:10090">Mus musculus</span>
###xml 750 758 <span type="species:ncbi:9606">patients</span>
The c.1172G>A variation resulted in a substitution of arginine (a strongly basic residue) to glutamine (a small polar amino acid; p.Arg391Gln), with a residue weight of one on Blosum 62 and "benign" or "tolerated" effect by  and , respectively. The arginine in this position was conserved between different species except in Rattus norvegicus and Mus musculus, whereas it varied in different members of Group III mGluRs (Figures 1D, E). The residue with variation is in the NH2-terminal domain and nearby one of the key positions of the glutamate binding pocket p.Lys400 [40], presumably and, therefore, is presumed to affect the receptor family ligand binding region according to domain analyzing databases. However, this variation was found in two patients and four controls, with no statistical significance on continuity correction of Pearson's chi2 test (Table 3).
###end p 30
###begin p 31
###xml 468 481 468 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figures 1D, E</xref>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
The c.1537G>A variation was found in three high myopia patients, where two were heterozygous and one homozygous. It resulted in a substitution of a hydrophobic valine by a highly conserved -containing and polar methionine (p.Val513Met), with a Blosum 62 score of one and a "benign" or "tolerated" effect by the abovementioned online tools. Residues 513 to 564 were predicted to form a highly conserved extracellular domain of family 3 GPCR forming disulphide bridges (Figures 1D, E). The function of this region remains uncertain but may play a role in calcium sensing and proper trafficking of proteins [41,42]. Residue 524 is predicted to be one of the nuclear localization signals of mGluR6. Residue 513 may play a role in nuclear localization and translocation of mGluR6.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r45">45</xref>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r49">49</xref>
###xml 1061 1063 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r50">50</xref>
###xml 1064 1066 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r52">52</xref>
High myopia usually occurs alone (nonsyndromic) but, in rare cases, may present as a sign in a number of syndromes (syndromic). Genetic factors have been demonstrated to play an important role in the development of high myopia [43,44]. The genes responsible for nonsydromic high myopia are mostly unknown although identification of such genes has been sought by using various approaches, including linkage analysis, case-control association study, and sequence analyzing of candidate genes [45]. Of these, a number of studies have tested the association of nonsydromic high myopia with common SNPs in genes responsible for syndromic high myopia but, unfortunately, the results are inconclusive and controversial in general [40,46-49]. This approach is based on the understanding that the genetic basis of complex diseases is associated with common variant (common disease, common variant [CDCV]). However, routine association study of common SNPs may not discover rare variations that might contribute to complex diseases (common disease, rare variant [CDRV]) [50-52]. Sequencing the functional regions of the target gene, as in this study, would detect such rare variations as well as mutations, which should be a preferable approach for a disease like high myopia where both Mendelian traits and complex traits are involved.
###end p 33
###begin p 34
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 191 195 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 470 474 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 683 687 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 756 760 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM6</italic>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
###xml 271 279 <span type="species:ncbi:9606">patients</span>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
###xml 702 707 <span type="species:ncbi:9606">human</span>
Here in this study, the entire coding and adjacent intronic regions of GRM6 were sequenced for 96 patients with nonsyndromic high myopia. Consequently, four novel variations were detected in GRM6 of the Chinese patients with high myopia, where three were only present in patients but not among the 96 controls. These variations were predicted to affect the functions of the encoded proteins if the mutant allele is expressed. This was the first sequencing evaluation of GRM6 in a group of patients with high myopia. The information obtained based on the current case-control sequence analyzing may not lead to a definite conclusion; however, it not only expands our understanding of GRM6 variations in human beings but also may suggest a potential role of GRM6 rare variations in the development of myopia in rare cases. Further studies in other ethnic populations may provide useful information to verify our findings.
###end p 34
###begin title 35
Acknowledgments
###end title 35
###begin p 36
###xml 22 30 <span type="species:ncbi:9606">patients</span>
The authors thank all patients and normal controls for their participation. This study was supported in part by grants 30772390 from the National Natural Science Foundation of China, Grant 7001571 and 8251008901000020 from the Natural Science Foundation of Guangdong Province. Prof. Qingjiong Zhang is a recipient of the National Science Fund for Distinguished Young Scholars (30725044).
###end p 36
###begin title 37
References
###end title 37
###begin article-title 38
Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate.
###end article-title 38
###begin article-title 39
###xml 75 80 <span type="species:ncbi:9606">human</span>
The whole nucleotide sequence and chromosomal localization of the gene for human metabotropic glutamate receptor subtype 6.
###end article-title 39
###begin article-title 40
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 84 90 <span type="species:ncbi:9913">bovine</span>
###xml 110 113 <span type="species:ncbi:10116">rat</span>
Functional coupling of a human retinal metabotropic glutamate receptor (hmGluR6) to bovine rod transducin and rat Go in an in vitro reconstitution system.
###end article-title 40
###begin article-title 41
Specific deficit of the ON response in visual transmission by targeted disruption of the mGluR6 gene.
###end article-title 41
###begin article-title 42
Ionotropic and metabotropic glutamate receptor structure and pharmacology.
###end article-title 42
###begin article-title 43
Allelic variance between GRM6 mutants, Grm6nob3 and Grm6nob4 results in differences in retinal ganglion cell visual responses.
###end article-title 43
###begin article-title 44
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
Comparisons of structural and functional abnormalities in mouse b-wave mutants.
###end article-title 44
###begin article-title 45
Regulation of ON bipolar cell activity.
###end article-title 45
###begin article-title 46
###xml 110 115 <span type="species:ncbi:9606">Human</span>
Primate Retinal Signaling Pathways: Suppressing ON-Pathway Activity in Monkey With Glutamate Analogues Mimics Human CSNB1-NYX Genetic Night Blindness.
###end article-title 46
###begin article-title 47
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Night blindness and abnormal cone electroretinogram ON responses in patients with mutations in the GRM6 gene encoding mGluR6.
###end article-title 47
###begin article-title 48
Mutations in GRM6 cause autosomal recessive congenital stationary night blindness with a distinctive scotopic 15-Hz flicker electroretinogram.
###end article-title 48
###begin article-title 49
Congenital stationary night blindness and a "Schubert-Bornschein" type electrophysiology in a family with dominant inheritance.
###end article-title 49
###begin article-title 50
The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein.
###end article-title 50
###begin article-title 51
Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness.
###end article-title 51
###begin article-title 52
Congenital stationary night blindness: report of an autosomal recessive family and linkage analysis.
###end article-title 52
###begin article-title 53
CSNB1 in Chinese families associated with novel mutations in NYX.
###end article-title 53
###begin article-title 54
Novel mutations in CACNA1F and NYX in Dutch families with X-linked congenital stationary night blindness.
###end article-title 54
###begin article-title 55
Mutations in the CACNA1F and NYX genes in British CSNBX families.
###end article-title 55
###begin article-title 56
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
High susceptibility to experimental myopia in a mouse model with a retinal on pathway defect.
###end article-title 56
###begin article-title 57
Mutations in NYX of individuals with high myopia, but without night blindness.
###end article-title 57
###begin article-title 58
Congenital stationary night blindness associated with mutations in GRM6 encoding glutamate receptor MGluR6.
###end article-title 58
###begin article-title 59
Evaluation of EGR1 as a candidate gene for high myopia.
###end article-title 59
###begin article-title 60
Detection of congenital color vision defects using heteroduplex-SSCP analysis.
###end article-title 60
###begin article-title 61
A sensitive non-radioactive PCR-RFLP analysis for detecting point mutations at 12th codon of oncogene c-Ha-ras in DNAs of gastric cancer.
###end article-title 61
###begin article-title 62
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human non-synonymous SNPs: server and survey.
###end article-title 62
###begin article-title 63
###xml 30 35 <span type="species:ncbi:9606">human</span>
Towards a structural basis of human non-synonymous single nucleotide polymorphisms.
###end article-title 63
###begin article-title 64
###xml 26 31 <span type="species:ncbi:9606">human</span>
Prediction of deleterious human alleles.
###end article-title 64
###begin article-title 65
Predicting deleterious amino acid substitutions.
###end article-title 65
###begin article-title 66
Automated splicing mutation analysis by information theory.
###end article-title 66
###begin article-title 67
Improved splice site detection in Genie.
###end article-title 67
###begin article-title 68
WoLF PSORT: protein localization predictor.
###end article-title 68
###begin article-title 69
Computational prediction of subcellular localization.
###end article-title 69
###begin article-title 70
SMART, a simple modular architecture research tool: identification of signaling domains.
###end article-title 70
###begin article-title 71
SMART 6: recent updates and new developments.
###end article-title 71
###begin article-title 72
pTARGET [corrected] a new method for predicting protein subcellular localization in eukaryotes.
###end article-title 72
###begin article-title 73
pTARGET: a web server for predicting protein subcellular localization.
###end article-title 73
###begin article-title 74
STRING 7--recent developments in the integration and prediction of protein interactions.
###end article-title 74
###begin article-title 75
Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+.
###end article-title 75
###begin article-title 76
Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor.
###end article-title 76
###begin article-title 77
High myopia is not associated with the SNPs in the TGIF, lumican, TGFB1, and HGF genes.
###end article-title 77
###begin article-title 78
Night blindness-associated mutations in the ligand-binding, cysteine-rich, and intracellular domains of the metabotropic glutamate receptor 6 abolish protein trafficking.
###end article-title 78
###begin article-title 79
Metabotropic glutamate receptor-mediated LTD involves two interacting Ca(2+) sensors, NCS-1 and PICK1.
###end article-title 79
###begin article-title 80
Interactions of genes and environment in myopia.
###end article-title 80
###begin article-title 81
Complex trait genetics of refractive error.
###end article-title 81
###begin article-title 82
###xml 46 51 <span type="species:ncbi:9606">human</span>
A review of current approaches to identifying human genes involved in myopia.
###end article-title 82
###begin article-title 83
Candidate gene and locus analysis of myopia.
###end article-title 83
###begin article-title 84
COL1A1 and COL2A1 genes and myopia susceptibility: evidence of association and suggestive linkage to the COL2A1 locus.
###end article-title 84
###begin article-title 85
The COL1A1 gene and high myopia susceptibility in Japanese.
###end article-title 85
###begin article-title 86
Systematic assessment of the tagging polymorphisms of the COL1A1 gene for high myopia.
###end article-title 86
###begin article-title 87
Common vs. rare allele hypotheses for complex diseases.
###end article-title 87
###begin article-title 88
Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes.
###end article-title 88
###begin article-title 89
Common and rare variants in multifactorial susceptibility to common diseases.
###end article-title 89

